Prime Medicine Inc (PRME)
3.345
-0.25
(-6.95%)
USD |
NASDAQ |
Nov 15, 16:00
3.34
0.00 (0.00%)
After-Hours: 20:00
Prime Medicine Total Assets (Quarterly): 332.78M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 332.78M |
| June 30, 2024 | 259.70M |
| March 31, 2024 | 311.38M |
| December 31, 2023 | 193.85M |
| September 30, 2023 | 239.14M |
| June 30, 2023 | 280.86M |
| Date | Value |
|---|---|
| March 31, 2023 | 316.95M |
| December 31, 2022 | 360.31M |
| September 30, 2022 | 215.26M |
| June 30, 2022 | 247.60M |
| December 31, 2021 | 301.86M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
193.85M
Minimum
Dec 2023
360.31M
Maximum
Dec 2022
278.16M
Average
280.86M
Median
Jun 2023
Total Assets (Quarterly) Benchmarks
| Bristol-Myers Squibb Co | 93.67B |
| Molecular Templates Inc | 26.70M |
| CEL-SCI Corp | 24.07M |
| AIM ImmunoTech Inc | 15.72M |
| IGC Pharma Inc | 10.59M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 143.28M |
| Shareholders Equity (Quarterly) | 189.50M |
| Current Ratio | 6.497 |